HaroldRCollardMD
Pulmonology • Berkeley, CACritical Care Medicine, Interstitial Lung Diseases
Professor, Medicine Associate Vice Chancellor of Clinical Research UCSF School of Medicine
Dr. Collard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3100 San Pablo Avenue
Berkeley, CA 94702Phone+1 510-985-5200
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
University of California (San Francisco)Residency, Internal Medicine, 1997 - 2001
Duke University School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1999 - 2026
CO State Medical License 2002 - 2005
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease
- Dyspnea in Patients With Pulmonary Fibrosis Start of enrollment: 2008 Jan 01
- The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 2547 citationsAn Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstiti...William D. Travis, Ulrich Costabel, David M Hansell, Talmadge E. King, David A. Lynch
American Journal of Respiratory and Critical Care Medicine. 2013-09-15 - 168 citationsEfficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K. Brown, Harold R. Collard, Vincent Cottin, Kevin F. Gibson
The Lancet. Respiratory Medicine. 2017-01-01 - 814 citationsIdiopathic pulmonary fibrosisLuca Richeldi, Harold R. Collard, Mark Jones
Lancet. 2017-05-13
Lectures
- Update in Interstitial Lung Disease: Diagnosis and ManagementUniversity of California, San Francisco, California - 5/5/2012
- Adding Insult to Injury: Complications of Idiopathic Pulmonary Fibrosis2013 International Conference, Philadelphia, Pennsylvania, USA
- Adding Insult to Injury: Complications of Idiopathic Pulmonary FibrosisAmerican Thoracic Society, 2013 International Conference, Philadelphia, Pennsylvania, USA
Other
- Bronchocentric granulomatosisCollard HR, King TE
http://www.uptodate.com/contents/bronchocentric-granulomatosis
UpToDate, Wolters Kluwer Health - 2012-05-11 - Pulmonary lymphomatoid granulomatosisCollard HR, King TE
http://www.uptodate.com/contents/pulmonary-lymphomatoid-granulomatosis
UpToDate, Wolters Kluwer Health - 2012-05-11
Press Mentions
- UCI to Lead Transfer of UC COVID-19 Patient Information to Federal DatabaseMarch 24th, 2021
Pandemic Forces Suspension of Dozens of Clinical Trials in Northern CaliforniaMay 25th, 2020
Pulmonary Fibrosis Foundation Creates Website to Help Patients Find Clinical TrialsFebruary 13th, 2018- Join now to see all
Grant Support
- Defining Acute Exacerbations Of Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2007–2011
- Apoptotic Cell Removal In Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2004
Committees
- Member, ATS/ERS/JRS/ALAT Committee on Treatment of IPF, American Thoracic Society 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
